Synlogic Operating Company, Inc. Patent Application Trends in 2024

Synlogic Operating Company, Inc. patent applications in 2024

Error creating thumbnail: File missing

Top 10 Technology Areas

• C12N15/70 (No explanation available)
  • Count: 5 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)
• A61K35/741 (No explanation available)
  • Count: 4 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)
• C07K14/245 (No explanation available)
  • Count: 4 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)
• C12N15/52 (No explanation available)
  • Count: 3 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)
• C12N9/88 (No explanation available)
  • Count: 3 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)
• A61K35/74 (No explanation available)
  • Count: 3 patents
  • Example: 20240180974. MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS simplified abstract (Synlogic Operating Company, Inc.)
• A61K38/20 (No explanation available)
  • Count: 2 patents
  • Example: 20240180974. MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS simplified abstract (Synlogic Operating Company, Inc.)
• A61K2035/115 (No explanation available)
  • Count: 2 patents
  • Example: 20240197843. BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL simplified abstract (Synlogic Operating Company, Inc.)
• C12R2001/19 (No explanation available)
  • Count: 2 patents
  • Example: 20240191176. BACTERIA ENGINEERED TO SECRETE ACTIVE PROTEINS simplified abstract (Synlogic Operating Company, Inc.)
• C12Y401/01057 (No explanation available)
  • Count: 1 patents
  • Example: 20240102024. RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF simplified abstract (Synlogic Operating Company, Inc.)

Emerging Technology Areas

• A61P3/00 (No explanation available)
  • Count: 1 patents
  • Example: 20240082316. MICROORGANISMS ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA simplified abstract (Synlogic Operating Company, Inc.)
• A61K9/0053 (No explanation available)
  • Count: 1 patents
  • Example: 20240082316. MICROORGANISMS ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA simplified abstract (Synlogic Operating Company, Inc.)
• C12Y207/02007 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• C12Y115/01001 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• C12Y103/08001 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• C12N9/1217 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• C12N9/001 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• A61K38/446 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• A61K38/26 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)
• A61K38/2066 (No explanation available)
  • Count: 1 patents
  • Example: 20240110192. BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER simplified abstract (Synlogic Operating Company, Inc.)

Top Inventors

• Vincent M. Isabella of Medford MA (US) (4 patents)
• Dean Falb of Sherborn MA (US) (3 patents)
• Paul F. Miller of Salem CT (US) (3 patents)
• Yves Millet of Newton MA (US) (3 patents)
• Jonathan W. Kotula of Berkeley CA (US) (2 patents)
• Michael James of Melrose MA (US) (2 patents)
• Dylan Alexander Carlin of Jamaica Plain MA (US) (1 patent)
• Jonathan McMurry of Boston MA (US) (1 patent)
• Theodore Carlton Moore, III of Cambridge MA (US) (1 patent)
• Mylene Perreault of Lexington MA (US) (1 patent)

Patent Categories

Error creating thumbnail: File missing

Geographical Distribution of Inventors

Geographical Distribution of US Inventors